2. Academic Validation
  3. Antibacterial activity of novel bacterial topoisomerase inhibitors against key veterinary pathogens

Antibacterial activity of novel bacterial topoisomerase inhibitors against key veterinary pathogens

  • Vet Microbiol. 2023 Jul 29;284:109840. doi: 10.1016/j.vetmic.2023.109840.
Hilary A Phelps 1,  Michael Kuhn 1,  Yanran Lu 2,  Sandip Vibhute 2,  Jeffrey L Watts 1,  Mark J Mitton-Fry 3
Affiliations

Affiliations

  • 1 Global Therapeutics, Anti-Infectives Research, Zoetis, 333 Portage Street, Kalamazoo, MI 49007, United States.
  • 2 Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210, United States.
  • 3 Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210, United States. Electronic address: mitton-fry.1@osu.edu.
PMID: 37531840 DOI: 10.1016/j.vetmic.2023.109840
Abstract

Multidrug-resistant bacteria infect companion Animals and livestock in addition to their devastating impact on human health. Novel Bacterial Topoisomerase Inhibitors (NBTIs) with excellent activity against Gram-positive bacteria have previously been identified as promising new Antibacterial agents. Herein, we evaluate the Antibacterial activity of these NBTIs against a variety of important veterinary pathogens and demonstrate outstanding in vitro activity, especially against staphylococci.

Keywords

Antagonists & Inhibitors; Mastitis; Staphylococcus.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z